This announcement is a separate document:
東瑞製藥：須予披露交易有關非布司他的上市許可持有人
DAWNRAYS PHARMA: DISCLOSEABLE TRANSACTION MARKETING AUTHORIZATION HOLDER (MAH) IN RESPECT OF FEBUXOSTAT
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.